{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:23:51Z","timestamp":1790641431331,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1A6A1A03015642"],"award-info":[{"award-number":["2017R1A6A1A03015642"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jgr.2018.12.012","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T02:54:51Z","timestamp":1546829691000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Medicinal potential of Panax ginseng and its ginsenosides in atopic dermatitis treatment"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3688-9131","authenticated-orcid":false,"given":"Laura Rojas","family":"Lorz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Youl","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgr.2018.12.012_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4168\/aair.2016.8.3.181","article-title":"A\u00a0comprehensive review of the treatment of atopic eczema","volume":"8","author":"Lee","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jgr.2018.12.012_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/354250","article-title":"Atopic dermatitis: natural history, diagnosis, and treatment","volume":"2014","author":"Thomsen","year":"2014","journal-title":"ISRN Allergy"},{"key":"10.1016\/j.jgr.2018.12.012_bib4","first-page":"1519","article-title":"Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies","volume":"5","author":"Boguniewicz","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5142\/jgr.2012.36.3.225","article-title":"Ginseng in traditional herbal prescriptions","volume":"36","author":"Park","year":"2012","journal-title":"J\u00a0Ginseng Res"},{"key":"10.1016\/j.jgr.2018.12.012_bib6","article-title":"Effects of ginsenoside Rb\u2081 on skin changes","volume":"2012","author":"Kimura","year":"2012","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.jgr.2018.12.012_bib7","series-title":"Special paper atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section","author":"Nowicki","year":"2015"},{"key":"10.1016\/j.jgr.2018.12.012_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/all.12184","article-title":"Immunology of atopic eczema: overcoming the Th1\/Th2 paradigm","volume":"68","author":"Eyerich","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jgr.2018.12.012_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2017.10.002","article-title":"Barrier dysfunction in the skin allergy","volume":"67","author":"Egawa","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jgr.2018.12.012_bib10","first-page":"110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J\u00a0Clin Cell Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jgr.2018.12.012_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jgr.2018.12.012_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/jid.2008.259","article-title":"Atopic dermatitis: a disease caused by innate immune defects?","volume":"129","author":"De Benedetto","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib14","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/jid.2008.283","article-title":"A\u00a0role for Th17 cells in the immunopathogenesis of atopic dermatitis?","volume":"128","author":"Cesare","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jgr.2016.02.003","article-title":"Korean red ginseng improves atopic dermatitis-like skin lesions by suppressing expression of proinflammatory cytokines and chemokines in\u00a0vivo and in\u00a0vitro","volume":"41","author":"Kee","year":"2017","journal-title":"J\u00a0Ginseng Res"},{"key":"10.1016\/j.jgr.2018.12.012_bib16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1248\/bpb.29.1862","article-title":"Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models","volume":"29","author":"Bae","year":"2006","journal-title":"Biol Pharmaceut Bull"},{"key":"10.1016\/j.jgr.2018.12.012_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5142\/jgr.2011.35.4.479","article-title":"Effects of Korean red ginseng extract for the treatment of atopic dermatitis-like skin lesions in mice","volume":"35","author":"Sohn","year":"2011","journal-title":"J\u00a0Ginseng Res"},{"key":"10.1016\/j.jgr.2018.12.012_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4103\/0019-5154.193674","article-title":"Current understanding in pathogenesis of atopic dermatitis","volume":"61","author":"McPherson","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib19","unstructured":"Kawasaki H, Kubo A, Sasaki T, Amagai M. Loss-of-function mutations within the Filaggrin gene and atopic dermatitis."},{"key":"10.1016\/j.jgr.2018.12.012_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.10-RAI-0270","article-title":"Filaggrin gene defects and the risk of developing allergic disorders","volume":"60","author":"Osawa","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.jgr.2018.12.012_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","article-title":"Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches","volume":"134","author":"Leung","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.07.060","article-title":"Application of moisturizer to neonates prevents development of atopic dermatitis","volume":"134","author":"Horimukai","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","article-title":"Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention","volume":"134","author":"Simpson","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2340\/00015555-1188","article-title":"Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates","volume":"92","author":"Su\u00e1rez","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jgr.2018.12.012_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","article-title":"Mediators of chronic pruritus in atopic dermatitis: getting the itch out?","volume":"51","author":"Mollanazar","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","article-title":"An assessment of the use of antihistamines in the management of atopic dermatitis","volume":"79","author":"He","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajd.12313","article-title":"Adverse effects of topical corticosteroids in paediatric eczema: australasian consensus statement","volume":"56","author":"Mooney","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdermsci.2009.02.002","article-title":"Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis","volume":"54","author":"El-Batawy","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jgr.2018.12.012_bib30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/bjd.15235","article-title":"Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists","volume":"176","author":"Taylor","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib31","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(00)05114-X","article-title":"Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial","volume":"357","author":"Reynolds","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jgr.2018.12.012_bib32","article-title":"Methotrexate versus cyclosporine in adults with moderate-to-severe atopic dermatitis: a Phase III randomized noninferiority trial","volume":"6","author":"Goujon","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jgr.2018.12.012_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-\u03b1 antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.adengl.2012.08.002","article-title":"Omalizumab for the treatment of atopic dermatitis","volume":"103","author":"Fern\u00e1ndez-Ant\u00f3n Mart\u00ednez","year":"2012","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"key":"10.1016\/j.jgr.2018.12.012_bib36","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of\u00a0Dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jgr.2018.12.012_bib37","article-title":"An insight into ginsenoside metabolite compound K as a potential tool for skin disorder. Evidence-based complementary and alternative medicine","volume":"2018","author":"Kim","year":"2018","journal-title":"eCAM"},{"key":"10.1016\/j.jgr.2018.12.012_bib38","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2174\/1381612822666161021152322","article-title":"Ginseng in dermatology: a review","volume":"23","author":"Sarvenaz","year":"2017","journal-title":"Cur Pharmaceut Des"},{"key":"10.1016\/j.jgr.2018.12.012_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5021\/ad.2018.30.3.304","article-title":"The beneficial effect of Korean red ginseng extract on atopic dermatitis patients: an 8 weeks open, noncomparative clinical study","volume":"30","author":"Kim","year":"2018","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jgr.2018.12.012_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5142\/jgr.2011.35.2.149","article-title":"Efficacy of korean red ginseng in the treatment of atopic dermatitis","volume":"35","author":"Lee","year":"2011","journal-title":"J\u00a0Ginseng Res"},{"key":"10.1016\/j.jgr.2018.12.012_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jep.2012.11.006","article-title":"Effects of Korean red ginseng extract on the prevention of atopic dermatitis and its mechanism on early lesions in a murine model","volume":"145","author":"Cho","year":"2013","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jgr.2018.12.012_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3346\/jkms.2017.32.4.679","article-title":"Therapeutic effects of Korean red ginseng extract in a murine model of atopic dermatitis: anti-pruritic and anti-inflammatory mechanism","volume":"32","author":"Lee","year":"2017","journal-title":"J\u00a0Kor Med Sci"},{"key":"10.1016\/j.jgr.2018.12.012_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1254\/jphs.11182FP","article-title":"Red ginseng inhibits scratching behavior associated with atopic dermatitis in experimental animal models","volume":"118","author":"Samukawa","year":"2012","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jgr.2018.12.012_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.fct.2013.02.037","article-title":"Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC\/Nga mice and TNF-\u03b1\/IFN-\u03b3-induced TARC activation in HaCaT cells","volume":"56","author":"Choi","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jgr.2018.12.012_bib45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1248\/bpb.b17-00124","article-title":"Effects of gintonin-enriched fraction in an atopic dermatitis animal model: involvement of autotaxin regulation","volume":"40","author":"Lee","year":"2017","journal-title":"Biol Pharmaceut Bull"},{"key":"10.1016\/j.jgr.2018.12.012_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jep.2013.10.058","article-title":"20-O-\u03b2-d-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC\/Nga mice","volume":"151","author":"Kim","year":"2014","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jgr.2018.12.012_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jphs.2017.11.002","article-title":"Red ginseng extracts attenuate skin inflammation in atopic dermatitis through p70 ribosomal protein S6 kinase activation","volume":"136","author":"Osada-Oka","year":"2018","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jgr.2018.12.012_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.05.038","article-title":"Efficacy of omalizumab in patients with atopic dermatitis: a systematic review and meta-analysis","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845318304214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845318304214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:13:16Z","timestamp":1761124396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845318304214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1226845318304214"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2018.12.012","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medicinal potential of Panax ginseng and its ginsenosides in atopic dermatitis treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2018.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}